167 related articles for article (PubMed ID: 27295037)
1. microRNA-153 Targets mTORC2 Component Rictor to Inhibit Glioma Cells.
Cui Y; Zhao J; Yi L; Jiang Y
PLoS One; 2016; 11(6):e0156915. PubMed ID: 27295037
[TBL] [Abstract][Full Text] [Related]
2. MiR-424/503-mediated Rictor upregulation promotes tumor progression.
Oneyama C; Kito Y; Asai R; Ikeda J; Yoshida T; Okuzaki D; Kokuda R; Kakumoto K; Takayama K; Inoue S; Morii E; Okada M
PLoS One; 2013; 8(11):e80300. PubMed ID: 24244675
[TBL] [Abstract][Full Text] [Related]
3. Conditional astroglial Rictor overexpression induces malignant glioma in mice.
Bashir T; Cloninger C; Artinian N; Anderson L; Bernath A; Holmes B; Benavides-Serrato A; Sabha N; Nishimura RN; Guha A; Gera J
PLoS One; 2012; 7(10):e47741. PubMed ID: 23077666
[TBL] [Abstract][Full Text] [Related]
4. mTORC2 is required for proliferation and survival of TSC2-null cells.
Goncharova EA; Goncharov DA; Li H; Pimtong W; Lu S; Khavin I; Krymskaya VP
Mol Cell Biol; 2011 Jun; 31(12):2484-98. PubMed ID: 21482669
[TBL] [Abstract][Full Text] [Related]
5. Functional Role of mTORC2 versus Integrin-Linked Kinase in Mediating Ser473-Akt Phosphorylation in PTEN-Negative Prostate and Breast Cancer Cell Lines.
Lee SL; Chou CC; Chuang HC; Hsu EC; Chiu PC; Kulp SK; Byrd JC; Chen CS
PLoS One; 2013; 8(6):e67149. PubMed ID: 23840605
[TBL] [Abstract][Full Text] [Related]
6. Involvement of Rictor/mTORC2 in cardiomyocyte differentiation of mouse embryonic stem cells
Zheng B; Wang J; Tang L; Tan C; Zhao Z; Xiao Y; Ge R; Zhu D
Int J Biol Sci; 2017; 13(1):110-121. PubMed ID: 28123351
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of 14-3-3 binding to Rictor of mTORC2 for Akt phosphorylation at Ser473 is regulated by selenoprotein W.
Jeon YH; Park YH; Kwon JH; Lee JH; Kim IY
Biochim Biophys Acta; 2013 Oct; 1833(10):2135-42. PubMed ID: 23680186
[TBL] [Abstract][Full Text] [Related]
8. Rictor/mTORC2 pathway in oocytes regulates folliculogenesis, and its inactivation causes premature ovarian failure.
Chen Z; Kang X; Wang L; Dong H; Wang C; Xiong Z; Zhao W; Jia C; Lin J; Zhang W; Yuan W; Zhong M; Du H; Bai X
J Biol Chem; 2015 Mar; 290(10):6387-96. PubMed ID: 25564616
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of the Hippo Pathway Component AMOTL2 by the mTORC2 Kinase Promotes YAP Signaling, Resulting in Enhanced Glioblastoma Growth and Invasiveness.
Artinian N; Cloninger C; Holmes B; Benavides-Serrato A; Bashir T; Gera J
J Biol Chem; 2015 Aug; 290(32):19387-401. PubMed ID: 25998128
[TBL] [Abstract][Full Text] [Related]
10. Tetraspanin 8-rictor-integrin α3 complex is required for glioma cell migration.
Pan SJ; Zhan SK; Pan YX; Liu W; Bian LG; Sun B; Sun QF
Int J Mol Sci; 2015 Mar; 16(3):5363-74. PubMed ID: 25761241
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma.
Hou G; Zhao Q; Zhang M; Fan T; Liu M; Shi X; Ren Y; Wang Y; Zhou J; Lu Z
Biomed Pharmacother; 2018 Oct; 106():1348-1356. PubMed ID: 30119206
[TBL] [Abstract][Full Text] [Related]
12. Targeting of mTORC2 may have advantages over selective targeting of mTORC1 in the treatment of malignant pheochromocytoma.
Zhang X; Wang X; Xu T; Zhong S; Shen Z
Tumour Biol; 2015 Jul; 36(7):5273-81. PubMed ID: 25666752
[TBL] [Abstract][Full Text] [Related]
13. DNMT3b Modulates Melanoma Growth by Controlling Levels of mTORC2 Component RICTOR.
Micevic G; Muthusamy V; Damsky W; Theodosakis N; Liu X; Meeth K; Wingrove E; Santhanakrishnan M; Bosenberg M
Cell Rep; 2016 Mar; 14(9):2180-2192. PubMed ID: 26923591
[TBL] [Abstract][Full Text] [Related]
14. mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor.
Masri J; Bernath A; Martin J; Jo OD; Vartanian R; Funk A; Gera J
Cancer Res; 2007 Dec; 67(24):11712-20. PubMed ID: 18089801
[TBL] [Abstract][Full Text] [Related]
15. Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma.
Benavides-Serrato A; Lee J; Holmes B; Landon KA; Bashir T; Jung ME; Lichtenstein A; Gera J
PLoS One; 2017; 12(4):e0176599. PubMed ID: 28453552
[TBL] [Abstract][Full Text] [Related]
16. mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling.
Julien LA; Carriere A; Moreau J; Roux PP
Mol Cell Biol; 2010 Feb; 30(4):908-21. PubMed ID: 19995915
[TBL] [Abstract][Full Text] [Related]
17. Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation.
Koo J; Wu X; Mao Z; Khuri FR; Sun SY
J Biol Chem; 2015 May; 290(22):14120-9. PubMed ID: 25897075
[TBL] [Abstract][Full Text] [Related]
18. Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers.
Morrison Joly M; Hicks DJ; Jones B; Sanchez V; Estrada MV; Young C; Williams M; Rexer BN; Sarbassov dos D; Muller WJ; Brantley-Sieders D; Cook RS
Cancer Res; 2016 Aug; 76(16):4752-64. PubMed ID: 27197158
[TBL] [Abstract][Full Text] [Related]
19. The miR-491-3p/mTORC2/FOXO1 regulatory loop modulates chemo-sensitivity in human tongue cancer.
Zheng G; Jia X; Peng C; Deng Y; Yin J; Zhang Z; Li N; Deng M; Liu X; Liu H; Lu M; Wang C; Gu Y; He Z
Oncotarget; 2015 Mar; 6(9):6931-43. PubMed ID: 25749387
[TBL] [Abstract][Full Text] [Related]
20. Depletion of Rictor, an essential protein component of mTORC2, decreases male lifespan.
Lamming DW; Mihaylova MM; Katajisto P; Baar EL; Yilmaz OH; Hutchins A; Gultekin Y; Gaither R; Sabatini DM
Aging Cell; 2014 Oct; 13(5):911-7. PubMed ID: 25059582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
